Clinical and Molecular Features of Morpheaform Basal Cell Carcinoma: A Systematic Review
Current Oncology · 13.11.2023 · 30 (11) · 9906-9928
DOI: 10.3390/curroncol30110720 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Current Oncology, online erschienen am 13.11.2023. Verfasst von Santina Conte und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3G 2M1, Canada. Hauptthemen laut MEDLINE: Basal Cell Carcinoma, Skin Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Terry Fox Research Institute, Fonds de Recherche du Québec - Santé, Cancer Research Society.
Abstract (Originalsprache)
Basal cell carcinoma (BCC) is the most common skin cancer, with a lifetime risk currently approaching up to 40% in Caucasians. Among these, some clinical and pathological BCC variants pose a higher risk due to their more aggressive biological behavior. Morpheaform BCC (morBCC), also known as sclerosing, fibrosing, or morpheic BCC, represents up to 5–10% of all BCC. Overall, morBCC carries a poorer prognosis due to late presentation, local tissue destruction, tumor recurrence, and higher frequency of metastasis. In this systematic review, we review the epidemiological, clinical, morphological, dermatoscopical, and molecular features of morBCC. After the title and abstract screening of 222 studies and the full-text review of 84 studies, a total of 54 studies met the inclusion criteria and were thus included in this review.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3G 2M1, Canada.
- Cancer Axis, Lady Davis Institute for Medical Research, Montreal, QC H3T 1E2, Canada.
- Division of Experimental Medicine, Department of Medicine, McGill University, Montreal, QC H3G 2M1, Canada.
- Division of Dermatology, Department of Medicine, McGill University, Montreal, QC H3G 2M1, Canada.
- Division of Dermatology, Department of Medicine, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.
ORCID-Profile: Santina Conte, Philippe Lefrançois
Förderung
- Terry Fox Research Institute
- Fonds de Recherche du Québec - Santé
- Cancer Research Society
- Lady Davis Institute for Medical Research
- Jewish General Hospital Foundation (Carole & Myer Bick, Kramer family)
- Jewish General Hospital Department of Medicine
- Fonds de recherche du Québec—Santé
- Marathon of Hope Cancer Centre Network—Terry Fox Research Institute
Zitieren
APA
Conte, S., Ghezelbash, S., Nallanathan, B., & Lefrançois, P. (2023). Clinical and Molecular Features of Morpheaform Basal Cell Carcinoma: A Systematic Review. Current Oncology, 30(11), 9906-9928. https://doi.org/10.3390/curroncol30110720
Vancouver
Conte S, Ghezelbash S, Nallanathan B, Lefrançois P. Clinical and Molecular Features of Morpheaform Basal Cell Carcinoma: A Systematic Review. Current Oncology. 2023;30(11):9906-9928. doi:10.3390/curroncol30110720
BibTeX
@article{Conte2023,
author = {Conte, Santina and Ghezelbash, Sarah and Nallanathan, Bonika and Lefrançois, Philippe},
title = {Clinical and Molecular Features of Morpheaform Basal Cell Carcinoma: A Systematic Review},
journal = {Current Oncology},
year = {2023},
volume = {30},
number = {11},
pages = {9906--9928},
doi = {10.3390/curroncol30110720}
}
EUVIMED